Shafiq Javed's scientific contributions

Publications (56)

Article
Full-text available
Background: Mini-One Anastomosis Gastric Bypass is a new operation that provides comparable outcomes to the common bariatric procedures. Revisional surgery is still needed after a number of MGB-OAGB procedures. The aim of this study is to report the causes and management of these revisions. Methods: From 2010 -2018, 925 MGB-OAGB operations were...
Article
Full-text available
The obesity surgery mortality risk score (OS-MRS) is a five-point scoring system stratifying the risk of post-operative mortality. Patients with a body mass index (BMI) > 60 may also carry an increased risk of peri-operative complications. Laparoscopic sleeve gastrectomy (LSG) as an initial procedure could reduce weight and associated comorbidity a...
Article
The aim of this study was to determine the safety and efficacy of laparoscopic duodenal switch (LDS) as a treatment option in a selected group of patients with morbid obesity. This retrospective analysis of a prospective database assessed the frequency of all complications and alterations in weight, body mass index (BMI), co-morbidity and quality o...
Article
Venous thromboembolism (VTE) after laparoscopic bariatric surgery is a significant cause of morbidity and mortality. The objective of the present study was to study the incidence of symptomatic VTE in extended thromboprophylaxis regimens using dalteparin at an independent hospital in England, United Kingdom. A prospective database of all patients u...
Article
Objective:- To determine the effectiveness, safety & side effects of intra-vesicle B.C.G immunotherapy in superficial bladder tumor after TURGB. Study design:- Observational study / Quasi-experimental. Place & duration of study:- Bolan Medical College Teaching Hospital Quetta, from August, 2004 to July, 2008. Patients & Methods:- Patients age range...
Article
Back ground:- Bladder Tumor is the second most common cancer of the genitor-urinary tract. Male to Female ratio: has been demonstrated as 3.5:1. Purpose of study:- To compare the efficacy of combined chemotherapy/or radical cystectomy with or without urinary diversion. Material and methods:- The present study was conducted on 26 consecutive patient...

Citations

... Since the implementation of mini-gastric bypass in 1997 by Rutledge, the procedure showed a steady increase and is meanwhile the third most popular bariatric operation after sleeve gastrectomy and Roux-Y gastric bypass [1]. Following positive short-and mid-term follow-up reports [2,3] and first randomized-trials [4], the International Federation for the Surgery of Obesity and Metabolic Open Access *Correspondence: undine.lange@googlemail.com Disorders (IFSO) recognized mini gastric bypass / one anastomosis bypass (MGB-OAGB) as effective and safe procedure. ...
... Although figure rating scales have been used to measure accuracy of judgment between perceived and actual body size using BMI-normed scales (9,10) their use has also been recommended for assessing BID by calculating the discrepancy between Current and Ideal ratings (7) . The larger the discrepancy between Current and Ideal ratings, the greater the BID an individual is thought to experience. ...
... Intestinal obstruction after laparoscopic DS can result from simple adhesions, port site hernia, incorrect anastomotic technique (twisting or narrowing) or ischemic stenosis. However, the most dangerous causes are internal herniation of the bowel and organo-axial rotation of the very long alimentary limb 40 . ...
... The procedure has historically been thought to be associated with more complications than less invasive alternatives such as the sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) [13] and it has been suggested that the good weight loss results achieved by DS are offset by high rates of post-operative nutritional sequelae [14][15][16]. Recent studies have however challenged these claims by demonstrating the role of comprehensive nutritional supplementation regimens in limiting post-operative nutritional deficiencies [17][18][19]. ...
... Based on the currently available data, the preferred agent for low-molecular-weight heparin therapy should be enoxaparin because the clinical experience with this drug is the most extensive in both obese patients as well as patients after bariatric surgery. [9][10][11][12] Even so, ongoing monitoring and dosage adjustments may still be necessary for low-molecular-weight heparins including enoxaparin because changes in body ALTERNATIVE VIEWPOINT Chan et al e27 composition and total weight can be very substantial in the first 6 months after RYGB. In summary, the data presented by Dr. Irwin and colleagues confirmed that the maintenance dose requirements for warfarin therapy require significant reduction in the first few months after RYGB to prevent overanticoagulation. ...
... The mean postoperative hospital stay was 3.54 days, which is quite similar to that reported by Magee et al. [14], with a mean of 3 days, ranged between 2 and 7 days. ...
... Unlike prior studies, we found a statistically significant increase in bleeding risk associated with PDH prophylaxis. Two small studies concluded that PDH prophylaxis was safe, based on the absence of an association with bleeding [19,32]. In the previously mentioned French study, Thereaux and colleagues reported a lower rate of re-hospitalization for bleeding among the group of patients who received PDH prophylaxis, a finding that is inconsistent with the pharmacologic mechanism of heparin products and lacks an alternative biologic explanation. ...